Children’s Minnesota is pleased to announced Dr. Nathan Gossai has received an Emerging Scientist Award for 2021 from Children’s Cancer Research Fund. The award is a $100,000 grant designed to develop the independent research of exceptional investigators still early in their careers.
David Gregornik, BS, PharmD, BCOP, Director, Pharmacogenomics Program, presented and moderated a panel discussion at the University of Minnesota Biennial Pharmacogenomics Conference. The event was held on Sept. 10-11 and focused on practical considerations for the implementation of pharmacogenomics into clinical care.
The pharmacogenomics program at Children’s Minnesota utilizes molecular testing to analyze genes in order to understand how a patient will metabolize medications.
Dr. Kris Ann Schultz is the first Endowed Chair holder in the Cancer and Blood Disorders program at Children’s Minnesota.
Children’s Minnesota has the largest pediatric cancer and blood disorders program in the Upper Midwest, caring for more than 58 percent of children diagnosed with cancer or blood disorders in Minnesota.
April 24, 2020, 8 a.m. – 2:30 p.m., St. Paul
Due to the recent developments and health safety precautions surrounding COVID-19, this event has been cancelled.
January 16, 2020 8 a.m. – January 26, 2020 9 a.m., Minneapolis
Suma Jacob, MD, MPH
April 20, 2017, 8 a.m. – 9 a.m., St. Paul
Meghan Cain, MD
December 13, 2016, 12 p.m. – 1 p.m., Minneapolis
This event is a 3-part series that covers all the regulations and application requirements for submission to the IRB.
November 8, 2016, 12 p.m. – 1 p.m., Minneapolis
This event is a 3-part series that covers all the regulations and application requirements for submission to the IRB.